Simplex Trading
KYMR icon

Simplex Trading’s Kymera Therapeutics KYMR Stock Holding History

Simplex Trading’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.83M Buy
42,100
+26,600
+172% +$2.29M ﹤0.01% 1234
2026
Q1 		$1.29M Buy
15,500
+14,400
+1,309% +$1.14M ﹤0.01% 2236
2025
Q4 		$85.6K Sell
1,100
-1,900
-63% -$128K ﹤0.01% 5154
2025
Q3 		$169K Sell
3,000
-27,100
-90% -$1.22M ﹤0.01% 5139
2025
Q2 		$1.31M Buy
30,100
+2,400
+9% +$82.6K ﹤0.01% 2501
2025
Q1 		$758K Buy
27,700
+24,400
+739% +$889K ﹤0.01% 2969
2024
Q4 		$132K Hold
3,300
– – ﹤0.01% 4927
2024
Q3 		$156K Sell
3,300
-700
-18% -$30.9K ﹤0.01% 4769
2024
Q2 		$119K Sell
4,000
-4,700
-54% -$163K ﹤0.01% 5194
2024
Q1 		$349K Sell
8,700
-2,200
-20% -$78.7K ﹤0.01% 4225
2023
Q4 		$277K Buy
10,900
+2,000
+22% +$35.8K ﹤0.01% 4314
2023
Q3 		$123K Sell
8,900
-6,700
-43% -$135K ﹤0.01% 4883
2023
Q2 		$358K Sell
15,600
-91,300
-85% -$2.62M ﹤0.01% 3651
2023
Q1 		$3.17M Sell
106,900
-50,400
-32% -$1.63M ﹤0.01% 1592
2022
Q4 		$3.93M Buy
157,300
+154,300
+5,143% +$4.11M ﹤0.01% 1366
2022
Q3 		$65K Buy
3,000
+300
+11% +$7.91K ﹤0.01% 6079
2022
Q2 		$53K Sell
2,700
-10,500
-80% -$245K ﹤0.01% 6414
2022
Q1 		$558K Buy
13,200
+12,900
+4,300% +$545K ﹤0.01% 3708
2021
Q4 		$19K Sell
300
-4,500
-94% -$262K ﹤0.01% 8411
2021
Q3 		$269K Buy
4,800
+200
+4% +$11.6K ﹤0.01% 5088
2021
Q2 		$223K Buy
+4,600
New +$200K ﹤0.01% 5514

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Simplex Trading's KYMR Position: Q2 2026 in Review

Simplex Trading opened a new position in Kymera Therapeutics (KYMR) in Q2 2026: 5,867 shares worth $673K. The stake represents ﹤0.01% of the portfolio and ranks #3253 among its holdings. This is a return to the name: Simplex Trading previously reported a position in KYMR as recently as Q4 2024.

Simplex Trading first reported a position in KYMR in Q2 2021 and has held it in 8 quarters since. 277 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • Simplex Trading held 5,867 shares of Kymera Therapeutics worth $673K as of Q2 2026.
  • Kymera Therapeutics was a new Simplex Trading position in Q2 2026.
  • Kymera Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #3253 holding.
  • Simplex Trading first reported a position in Kymera Therapeutics in Q2 2021 and has held it in 8 quarters since.
  • 277 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.